The Latest Breaking News from ACN

This Dividend Stock Yields 3.1% and Offers Massive Upside: Time to Buy?

Accenture's dividend yield is over 3.1%, and the stock offers strong upside potential. Is it a buy?

Barchart · Mar 6

Accenture Stock: Is Wall Street Bullish or Bearish?

Accenture has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Feb 6

Stocks Climb Before the Open on Micron Boost Ahead of U.S. Inflation Data

December S&P 500 E-Mini futures (ESZ25) are up +0.46%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.74% this morning as forecast-beating quarterly results and guidance from Micron boosted sentiment.

Barchart · Dec 18, 2025

Is Accenture Stock Underperforming the S&P 500?

While Accenture has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart · Nov 26, 2025

Accenture Stock: Analyst Estimates & Ratings

Accenture has considerably underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Nov 7, 2025

3 Dividend Hikes That Signal Renewed Strength in 2025

Dividends are on the rise for these three stocks to watch. THO, ACN, and HON have seen lackluster performance, but it's possible this could change.

MarketBeat · Oct 14, 2025

Accenture Expands AI Capabilities Through Decho Buyout, Eyes Broader Palantir Integration

Accenture Plc (NYSE:ACN) has acquired Decho, a U.K.-based technology and AI consultancy that specializes in Palantir Technologies Inc. (NYSE:PLTR) platforms. The acquisition aims to accelerate the implementation and scaling of AI-driven solutions across the health, defense, government, and commercial sectors.

Benzinga · Oct 14, 2025

These Analysts Slash Their Forecasts On Accenture After Q4 Results

Accenture plc (NYSE: ACN) posted better-than-expected fourth-quarter 2025 results on Thursday.

Benzinga · Sep 26, 2025

Accenture: Undervalued GenAI Leader or Snake Eating its Own Tail?

Accenture's GenAI bookings are growing by billions a quarter, and the stock is trading at a rock-bottom valuation. Is this a big opportunity or ominous sign?

MarketBeat · Sep 26, 2025

Accenture Posts Solid Growth — Can Restructuring And AI Push Secure Long-Term Profitability?

Accenture (NYSE: ACN) reported fourth-quarter revenue of $17.6 billion, topping expectations, with bookings rising 3% to $21.3 billion.

Benzinga · Sep 26, 2025